Showing results (51-60 of 894) with videos related to
Sort By:
Pageof 90
Expert Opinion on Investigational Drugs|November 17, 2006
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphomaFarhad Ravandi, Varsha GandhiLeukemia & Lymphoma|July 27, 2013
Acute myeloid leukemia in the elderly: do we know who should be treated and how?Aziz Nazha, Farhad RavandiBest Practice & Research. Clinical Haematology|December 6, 2020
The potential role of Bi-specific antibodies in acute myeloid leukemiaMusa Yilmaz, Farhad RavandiSeminars in Hematology|March 22, 2006
Purine analogues in advanced T-cell lymphoid malignanciesRazelle Kurzrock, Farhad RavandiClinical Lymphoma, Myeloma & Leukemia|March 7, 2025
SOHO State of the Art Updates and Next Questions Acute Myeloid Leukemia: Current Status and Next QuestionsVishrut Shah, Farhad RavandiFuture Oncology (London, England)|April 21, 2012
Efficacy of tosedostat, a novel, oral agent for elderly patients with relapsed or refractory acute myeloid leukemia: a review of the Phase II OPAL trialMichael S Mathisen, Farhad RavandiBritish Journal of Haematology|February 2, 2017
How I manage patients with hairy cell leukaemiaPhilip A Thompson, Farhad RavandiJournal of the National Comprehensive Cancer Network : JNCCN|August 11, 2012
Monitoring minimal residual disease in acute myeloid leukemia: ready for prime time?Farhad Ravandi, Jeffrey L JorgensenClinical Advances in Hematology & Oncology : H&O|December 5, 2017
A mind map for managing minimal residual disease in acute myeloid leukemiaChristopher B Benton, Farhad RavandiExpert Review of Hematology|March 3, 2023
Non-intensive acute myeloid leukemia therapies for older patientsRodrick Babakhanlou, Farhad Ravandi-KashaniPageof 90